1-3 of 3
Joseph F. Grosso
Close
Sort by
Journal Articles

Nivolumab in Patients with Relapsed or Refractory Hodgkin Lymphoma - Preliminary Safety, Efficacy and Biomarker Results of a Phase I Study

Philippe Armand, MD PhD, Stephen M. Ansell, MD PhD, Alexander M. Lesokhin, MD, Ahmad Halwani, MD, Michael M. Millenson, MD, Stephen J. Schuster, MD, John Timmerman, MD, Ivan Borrello, MD, Martin Gutierrez, MD, Emma C. Scott, MD, Deepika Cattry, MSc, CCRP, Bjoern Chapuy, MD PhD, Azra H. Ligon, PhD, Scott J. Rodig, MD PhD, Lili Zhu, MSc, Joseph F. Grosso, PhD, Su Young Kim, MD PhD, Margaret A. Shipp, MD
Journal: Blood
Blood (2014) 124 (21): 289.
https://doi.org/10.1182/blood.V124.21.289.289
Published: 2014
Journal Articles

Preliminary Results of a Phase I Study of Nivolumab (BMS-936558) in Patients with Relapsed or Refractory Lymphoid Malignancies

Alexander M. Lesokhin, MD, Stephen M. Ansell, MD PhD, Philippe Armand, MD PhD, Emma C. Scott, MD, Ahmad Halwani, MD, Martin Gutierrez, MD, Michael M. Millenson, MD, Adam D. Cohen, MD, Stephen J. Schuster, MD, Daniel Lebovic, Madhav V. Dhodapkar, MD, David Avigan, MD, Bjoern Chapuy, MD PhD, Azra H. Ligon, PhD, Scott J. Rodig, MD PhD, Deepika Cattry, MSc, CCRP, Lili Zhu, MSc, Joseph F. Grosso, PhD, Su Young Kim, MD PhD, Margaret A. Shipp, MD, Ivan Borrello, MD, John Timmerman, MD
Journal: Blood
Blood (2014) 124 (21): 291.
https://doi.org/10.1182/blood.V124.21.291.291
Published: 2014
Journal Articles

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

Monica V. Goldberg, Charles H. Maris, Edward L. Hipkiss, Andrew S. Flies, Lijie Zhen, Rubin M. Tuder, Joseph F. Grosso, Timothy J. Harris, Derese Getnet, Katharine A. Whartenby, Dirk G. Brockstedt, Thomas W. Dubensky, Jr, Lieping Chen, Drew M. Pardoll, Charles G. Drake
Journal: Blood
Blood (2007) 110 (1): 186–192.
https://doi.org/10.1182/blood-2006-12-062422
Published: 2007